Connect with us

biotech

Increasing cancer detection rates

(USA)

A leading life sciences company has confirmed it will harness cloud technology from Amazon Web Services (AWS) to support its efforts to detect cancer early.

California-headquartered GRAIL strives to facilitate the early detection of cancer, while it can still be treated, by combining genomics sequencing, machine learning and data science to ‘transform the way cancer is diagnosed’. It joins the likes of Novartis and Merck in running its cloud infrastructure from AWS.

Ken Drazan, Chief Business Officer at GRAIL, said: “In today’s complex and competitive global healthcare marketplace, technology is a cornerstone in our effort to develop solutions that detect cancer at its earliest stages. AWS’s cloud platform provides critical infrastructure as we scale our databases and computational tools to support our large population-scale clinical studies and the development of our early detection products.”

 

 

Newsletter Signup

Staff reporter
Written By

Advertisement

Horizon 2030: mission biotech

biotech

Flight path to greener skies

technology

Game-changing cancer therapy

biotech

Planetary love goes full circle

circular | fashion

Connect
Newsletter Signup